The prescribing population included 2,227,978 patients, representing 9,376,370 GLP-1 prescriptions between January 2024 and February 2026
It enhances colour while continuing to treat and protect your lips.
You can also explore more on our blog, including our related guides
Adherence and Patient Preference Adherence is where the differences between oral and injectable GLP-1 therapies become particularly important
In fact, some people find that the acidity of ACV can help with the absorption of certain nutrients
FDA-Compliant Peptide Selection Your provider should: Exclusively offer FDA-approved peptides or those compoundable under current FDA policy Refuse to prescribe non-approved compounds like Explain FDA approval status and off-label use when relevant Update protocols as FDA guidance changes Ask directly: Do you prescribe (insert research grade non-human peptide name) ? If the answer is yes, find a different provider